Boxiong Tang MD, PhD

Dr. Boxiong Tang brings over 27 years of experience in medicine, public health, and health economics & outcomes research (HEOR). Currently, he is the founder and principal of TZ Health, providing leadership and consulting services to healthcare organizations. Previously, he served as an AVP of HEOR at Agenus, responsible for HEOR strategies globally. He established the HEOR function to support the product launches and reimbursement globally. Before joining Agenus, Dr. Tang was the Executive Director/Head of HEOR at BeiGene and Sr. Director of Global HEOR at Teva Pharmaceutical. Senior Director of Health Outcomes Research at Pfizer Emerging Markets, Director of HEOR at JNJ, and GSK. He was also an adjunct professor of China Fudan University and the faculty of Zhejiang University Medical School.

Meanwhile, Dr. Tang was the 2016-2018 Chair of the HTA (Industry) Committee, Asia Consortium of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR), and a current member of the Asia Consortium Executive Committee. Also, he served as a Senior Fellow at Thomas Jefferson University, School of Population Health. Dr. Tang’s training includes an MD in Preventive Medicine, a PhD in Health Services Research, and an MPH in Health Planning and International Health. He has published more than 40 manuscripts in peer-reviewed journals, 100+ abstracts, speeches, and presentations in major scientific congresses. He is knowledgeable in the development of Health Technology Assessment around the world. In addition, he served on the Scientific Committees of the International Health Economics Association (iHEA/ASHE), the Society for Medical Decision Making (SMDM), and as a Peer Reviewer of the American Journal of Managed Care and the Cancer Research Journal.